We develop and produce high-quality specialty products made of glass and plastic, primarily for the pharma & life science industry. In addition to specific primary containers for a wide variety of substances and medicines, our product and service portfolio comprises complex drug delivery systems. We are one of the few companies in our sector to specialise equally in both of the major primary-material categories of importance in this demanding market, i.e. glass and plastic. We also look after our customers very intensively on the service side.
Through strong organic growth and targeted acquisitions particularly in the pharma segment, we have further expanded our market position over recent years. In almost all of our fields of business we rank today among the global market leaders. In all areas and particularly in the sector of pharma and |
 |
life sciences, our long-standing customers include very well-known, internationally leading companies.
Geographical proximity to its customers and their most important markets is a key criterion for us. We are represented in Europe, America and Asia by 37 production plants employing a total of 10,000 people.
The following chart shows the share of our total Group sales accounted for by the individual market segments, divisions and regions.
The origins of our Group go back to the glass factory founded by Ferdinand Heye in 1864 in the Gerresheim suburb of Düsseldorf. Only over the last two decades did we develop into the highly-specialized supplier, primarily to the pharma & life science industry, which we are today – with the help of targeted |
|
acquisitions and intensive development and refinement of know-how and technologies.
Structure
Our International business is split into four divisions, to which our individual Group companies are allocated:
. Tubular Glass
. Plastic Systems
. Moulded Glass
. Life Science Research
As independent organisational units our divisions have worldwide responsibility for development, production and marketing. |
|
|
